Bold Predictions for Human Genomics by 2030

About this Class

As a continuation of the NHGRI seminar series focused on the “Bold Predictions for Human Genomics by 2030,” please join us for the seventh seminar in the series on Thursday, September 16 from 3:00 – 4:30 pm ET. This seminar will focus on Bold Prediction #7: The clinical relevance of all encountered genomic variants will be readily predictable, rendering the diagnostic designation “variant of uncertain significance (VUS)” obsolete. Dr. Heidi Rehm of the Broad Institute, Harvard Medical School & Massachusetts General Hospital and Dr. Doug Fowler of University of Washington will use this prediction as an aspirational theme for their talks, highlighting their own work in the context of that theme and speculating about the next decade in their areas. The talks will be followed by a moderated question-and-answer session. All seminars will be open to the public and recorded for posting on GenomeTV.